Status:

RECRUITING

Effect of Breastfeeding on Lipid Profile and Cardiovascular Risk Markers in Women with Familial Hypercholesterolemia

Lead Sponsor:

Oslo University Hospital

Collaborating Sponsors:

University of Oslo

Conditions:

Familial Hypercholesterolemia

Eligibility:

FEMALE

18+ years

Brief Summary

The study aims to investigate the effects of breastfeeding on lipid profile and cardiovascular risk markers in women with familial hypercholesterolemia (FH) compared to women without FH. Women with FH...

Detailed Description

Patients with familial hypercholesterolemia (FH) have elevated plasma levels of LDL-cholesterol from first years of life. Cholesterol burden through life defines risk of cardiovascular disease. In wom...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for women with FH:
  • age 18 years or older,
  • confirmed diagnosis of FH through genetic testing or clinical assessment based on the Dutch Lipid Clinic Network,
  • singleton pregnancy in the third trimester,
  • a sufficient command of Norwegian, Dutch, Czech or English language.
  • Exclusion Criteria for women with FH:
  • Not filling the inclusion criteria.
  • Inclusion Criteria for women without FH:
  • age 18 years or older,
  • singleton pregnancy in the third trimester,
  • a sufficient command of Norwegian or English language.
  • Exclusion Criteria for women without FH:
  • known pre-pregnancy hypercholesterolemia,
  • a history of ASCVD.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT05367310

    Start Date

    May 1 2022

    End Date

    December 31 2026

    Last Update

    March 21 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University

    Prague, Czechia

    2

    Department of Internal Medicine, Erasmus MC Cardiovascular Institute

    Rotterdam, Netherlands

    3

    Oslo University Hospital

    Oslo, Norway